 |
인쇄하기
취소
|
KFDA panel to review 9 orphan drugs to resume.
9 orphan drugs including Rilutek (riluzole: Rhone poulenc-Rorer Korea) and Gleevec (Novartis Korea) seem to review their orphan drug positions again.
The KFDA planned a Central Pharmaceutical Review Council, Orphan Drug Subcommittee's meeting on Dec. 20 to review whether 9 orphan drugs having sold more than 1 million dollars (one billion won) in 2004 should keep their orphan drug positions.
...
The KFDA planned a Central Pharmaceutical Review Council, Orphan Drug Subcommittee's meeting on Dec. 20 to review whether 9 orphan drugs having sold more than 1 million dollars (one billion won) in 2004 should keep their orphan drug positions.
...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.